[1]
“Role of 18F-FDG PET/CT scan and MRI for Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Management”, Bangladesh J. Nuclear Med., vol. 28, no. 1, pp. 22–30, Apr. 2025, doi: 10.3329/bjnm.v28i1.79482.